Wood R - Search Results

1

Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.

Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A; International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration. Johnson LF, et al. Among authors: wood r. PLoS Med. 2013;10(4):e1001418. doi: 10.1371/journal.pmed.1001418. Epub 2013 Apr 9. PLoS Med. 2013. PMID: 23585736 Free PMC article.

2

Antiretroviral therapy in South Africa--can we do it?

Bekker LG, Wood R. Bekker LG, et al. Among authors: wood r. S Afr Med J. 2002 Mar;92(3):191-3. S Afr Med J. 2002. PMID: 12040936 Review. No abstract available.

3

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Badri M, Wilson D, Wood R. Badri M, et al. Among authors: wood r. Lancet. 2002 Jun 15;359(9323):2059-64. doi: 10.1016/S0140-6736(02)08904-3. Lancet. 2002. PMID: 12086758

4

Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.

Boulle A, Kenyon C, Skordis J, Wood R. Boulle A, et al. Among authors: wood r. S Afr Med J. 2002 Oct;92(10):811-7. S Afr Med J. 2002. PMID: 12432807

5

Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings.

Badri M, Wood R. Badri M, et al. Among authors: wood r. AIDS. 2003 Mar 7;17(4):541-5. doi: 10.1097/00002030-200303070-00009. AIDS. 2003. PMID: 12598774

6

Adherence is not a barrier to successful antiretroviral therapy in South Africa.

Orrell C, Bangsberg DR, Badri M, Wood R. Orrell C, et al. Among authors: wood r. AIDS. 2003 Jun 13;17(9):1369-75. doi: 10.1097/00002030-200306130-00011. AIDS. 2003. PMID: 12799558 Clinical Trial.

7

Nevirapine toxicity--implications for management of South African patients.

Wood R. Wood R. S Afr Med J. 2005 Apr;95(4):253-7. S Afr Med J. 2005. PMID: 15889848 Review. No abstract available.

8

Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Smit J, Middelkoop K, Myer L, Lindegger G, Swartz L, Seedat S, Tucker T, Wood R, Bekker LG, Stein DJ. Smit J, et al. Among authors: wood r. Afr Health Sci. 2005 Sep;5(3):198-206. doi: 10.5555/afhs.2005.5.3.198. Afr Health Sci. 2005. PMID: 16245989 Free PMC article. Review.

9

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme.

Lawn SD, Bekker LG, Myer L, Orrell C, Wood R. Lawn SD, et al. Among authors: wood r. AIDS. 2005 Nov 18;19(17):2050-2. doi: 10.1097/01.aids.0000191232.16111.f9. AIDS. 2005. PMID: 16260920 No abstract available.

10

Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

Lawn SD, Myer L, Wood R. Lawn SD, et al. Among authors: wood r. Clin Infect Dis. 2005 Dec 1;41(11):1683-4; author reply 1684. doi: 10.1086/498030. Clin Infect Dis. 2005. PMID: 16267745 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,465 results

Search Page

Filters